Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. ICORG 10-01, V5

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by ICORG- All Ireland Cooperative Oncology Research Group
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ICORG- All Ireland Cooperative Oncology Research Group
ClinicalTrials.gov Identifier:
NCT01566747
First received: March 8, 2012
Last updated: October 16, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)